Login

MicroStrategy CEO Michael Saylor shares insights on the future of the company. 00:10:00

Share On Facebook Share On Twitter

Saylor has served as Executive Chairman since August 2022. 

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:10:00
Rabobank's Robust Financial Performance and Strategic Initiatives | Bas Brouwers, CFO, Rabobank.
00:10:00
Understanding Your Personal Cash Flow: Key Tools and Strategies | Michelle Smalenberger, CEO, Financial Design Studio.
00:10:00
Exploring Canada's Uranium Frontier: Fission Uranium Corp.
00:10:00
DoTerra Royalties (ASX: DTRO): Australian-Based Iron Ore Royalty Company Focused on Sustainable Growth and High Earnings
00:10:00
Senior Resources: Advancing Twin Hills Gold Project in Namibia with Prominent Shareholders
00:10:00
Best Practices for Writing and Reviewing State Regulatory Communications
00:10:00
Muhammad Ali Discusses Hatch's Involvement and Insights at CIM Conference
00:10:00
Believes that learning and labor also known as EdTech and the Future of Work|Atin Batra, General Partner,27V fka Twenty Seven Ventures
00:10:00
Glenn August, Oak Hill Advisors CEO, Discusses $5 Billion Credit Investment Strategy | Glenn August, CEO, Oak Hill Advisors.
00:10:00
CEO Spotlight: MeridianLink CEO Nicolaas Vlok shares what excites him most about joining the #NYSECommunity now that his company is public.
00:00:00
Clive Dix BSc PhD HonFBPhS, CEO, C4X Discovery Holdings PLC
00:10:00
BigCommerce CEO Brent Bellm on the company's IPO | Brent Bellm, CEO, Bigcommerce Holdings Inc (NASDAQ: BIGC)

© 2017 - Neuhu+